Blood Transfusion Thresholds: Restrictive vs. Liberal Strategies

Red blood cell (RBC) transfusion decisions balance oxygen delivery benefits against risks (transfusion reactions, immunomodulation, infection, volume overload, cost). Evidence supports a restrictive strategy for most stable patients.

Evidence-Based Thresholds

Clinical ScenarioRecommended Hb ThresholdKey Trials
Stable, non-cardiac (ICU, ward)≤7 g/dL (70 g/L)TRICC, FOCUS, ABLE
Cardiovascular disease / ACS≤8 g/dL (80 g/L)MINT, REALITY; physiologic rationale
Acute hemorrhageBased on hemodynamics, ongoing loss, comorbidities—not Hb alone—
Chronic anemia (symptomatic)Transfuse for symptoms (dyspnea, angina, fatigue) not number—

Additional Decision Factors

  • Age, frailty, comorbidities (CAD, CVD, COPD)
  • Tissue oxygenation markers: lactate, ScvO₂, NIRS
  • Patient preferences (e.g., Jehovah's Witness)
  • Risks: TACO, TRALI, alloimmunization, infection (rare), iron overload (chronic)

Practical Approach

  1. Assess clinical stability—is the patient compensating?
  2. Apply threshold appropriate to category.
  3. Single-unit transfusion → reassess.
  4. Document indication, consent, pre/post Hb.

Clinical judgment integrating the whole picture remains paramount. Guidelines are guardrails, not substitutes for thinking.

Blood Disorders - Related Articles